Active substance | Vedolizumab |
Holder | Takeda |
Status | Closed |
Indication | Patients with Crohn disease that have failed at least 2 previous anti-TNF or for whom anti-TNF is contra-indicated |
Public documents | Approbation |
Information for the patient | |
Informed consent | |
Last update | 03/05/2016 |
Entyvio®
Last updated on 23/04/2024